Related Articles
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
Overexpression of miR‑106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1
miR‑210‑3p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3
Enforced expression of miR‑101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase‑2 pathway
MicroRNA‑106a confers cisplatin resistance in non‑small cell lung cancer A549 cells by targeting adenosine triphosphatase‑binding cassette A1